文献速递心脑血管急症重症综合管理与镇静镇痛

心脏手术同期行外科左心耳封堵与后续卒中及死亡风险的关联

Association of Surgical Left Atrial Appendage Occlusion With Subsequent Stroke and Mortality Among Patients Undergoing Cardiac Surgery.
PubMed 文献 · JAMA · 2018-01-01
一句话结论心脏手术同期行外科左心耳封堵与后续卒中及全因死亡风险降低相关,但需随机临床试验进一步明确其作用。

该回顾性队列研究利用美国大型行政数据库,纳入2009年1月1日至2017年3月30日期间接受冠状动脉旁路移植术或瓣膜手术的成年患者,最终随访至2017年3月31日。在75 782例患者中,4 374例(5.8%)同期行外科左心耳封堵,采用1:1倾向评分匹配平衡76个维度后,匹配组8590例。匹配分析显示,左心耳封堵与卒中风险降低(1.14 vs 1.59事件/100人年;HR 0.73,95%CI 0.56-0.96;P=0.03)及死亡风险降低(3.01 vs 4.30事件/100人年;HR 0.71,95%CI 0.60-0.84;P<0.001)相关。左心耳封堵还与房颤相关门诊就诊率(率比1.17,95%CI 1.10-1.24)和住院率(率比1.13,95%CI 1.05-1.21)升高相关。作者结论认为需进一步研究包括随机临床试验来更明确地确定外科左心耳封堵的作用。

要点

  • 在倾向评分匹配的8590例心脏手术患者中,同期左心耳封堵与卒中风险降低相关(1.14 vs 1.59事件/100人年;HR 0.73,95%CI 0.56-0.96;P=0.03)。
  • 同期左心耳封堵与全因死亡风险降低相关(3.01 vs 4.30事件/100人年;HR 0.71,95%CI 0.60-0.84;P<0.001)。
  • 在既往有房颤患者中,左心耳封堵与卒中风险降低(1.11 vs 1.71事件/100人年;HR 0.68,95%CI 0.50-0.92;P=0.01)和死亡风险降低(3.22 vs 4.93事件/100人年;HR 0.67,95%CI 0.56-0.80;P<0.001)相关。
  • 在无既往房颤患者中,左心耳封堵与术后房颤风险升高相关(27.7% vs 20.2%事件/100人年;HR 1.46,95%CI 1.22-1.73;P<0.001),卒中风险无显著差异(HR 0.95,95%CI 0.54-1.68)。
  • 左心耳封堵与房颤相关门诊就诊率升高相关(11.96 vs 10.26事件/人年;绝对差异1.70,95%CI 1.60-1.80;率比1.17,95%CI 1.10-1.24;P<0.001)和住院率升高相关(0.36 vs 0.32事件/人年;绝对差异0.04,95%CI 0.02-0.06;率比1.13,95%CI 1.05-1.21;P=0.002)。

适用人群与场景

  • 纳入标准:年龄≥18岁、拥有私人保险或Medicare Advantage、于2009年1月1日至2017年3月30日期间接受冠状动脉旁路移植术或瓣膜手术的成年患者。

研究设计与关键结果

  • 研究设计:回顾性队列研究,使用美国大型行政数据库,采用1:1倾向评分匹配平衡76个维度,按手术时既往房颤史分层。
  • 样本量:共75 782例心脏手术患者(平均年龄66.0岁,标准差11.2;女22 091例[29.2%];既往房颤25 721例[33.9%]),其中4 374例(5.8%)同期行左心耳封堵;平均随访2.1年(标准差1.9)。
  • 匹配人群:8590例倾向评分匹配患者(既往房颤6438/8590[74.9%],无既往房颤2152/8590[25.1%])。
  • 主要终点:左心耳封堵组 vs 无左心耳封堵组卒中发生率为1.14 vs 1.59事件/100人年(HR 0.73,95%CI 0.56-0.96;P=0.03);全因死亡率为3.01 vs 4.30事件/100人年(HR 0.71,95%CI 0.60-0.84;P<0.001)。
  • 既往房颤亚组:左心耳封堵组 vs 无左心耳封堵组卒中风险为1.11 vs 1.71事件/100人年(HR 0.68,95%CI 0.50-0.92;P=0.01);死亡风险为3.22 vs 4.93事件/100人年(HR 0.67,95%CI 0.56-0.80;P<0.001)。
  • 无既往房颤亚组:左心耳封堵组 vs 无左心耳封堵组卒中风险为1.23 vs 1.26事件/100人年(HR 0.95,95%CI 0.54-1.68);死亡风险为2.30 vs 2.49事件/100人年(HR 0.92,95%CI 0.61-1.37);术后房颤风险为27.7% vs 20.2%事件/100人年(HR 1.46,95%CI 1.22-1.73;P<0.001)。
  • 交互作用:既往房颤与左心耳封堵的交互项无统计学意义(卒中P=0.29,死亡P=0.16)。

证据类型、等级与局限

  • 证据类型:回顾性队列研究。
  • 局限:需进一步研究,包括随机临床试验,以更明确地确定外科左心耳封堵的作用。

对床旁实践的改变

  • 作者结论认为,在接受心脏手术的患者中,同期外科左心耳封堵与无外科左心耳封堵相比,与后续卒中及全因死亡风险降低相关。
  • 作者结论认为,需进一步研究,包括随机临床试验,以更明确地确定外科左心耳封堵的作用。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Surgical occlusion of the left atrial appendage (LAAO) may be performed during concurrent cardiac surgery. However, few data exist on the association of LAAO with long-term risk of stroke, and some evidence suggests that this procedure may be associated with subsequent development of atrial fibrillation (AF).

OBJECTIVE: To evaluate the association of surgical LAAO performed during cardiac surgery with risk of stroke, mortality, and development of subsequent AF.

DESIGN, SETTING, AND PARTICIPANTS: Retrospective cohort study using a large US administrative database that contains data from adult patients (≥18 years) with private insurance or Medicare Advantage who underwent coronary artery bypass graft (CABG) or valve surgery between January 1, 2009, and March 30, 2017, with final follow-up on March 31, 2017. One-to-one propensity score matching was used to balance patients on 76 dimensions to compare those with vs without LAAO, stratified by history of prior AF at the time of surgery.

EXPOSURES: Surgical LAAO vs no surgical LAAO during cardiac surgery.

MAIN OUTCOMES AND MEASURES: The primary outcomes were stroke (ie, ischemic stroke or systemic embolism) and all-cause mortality. The secondary outcomes were postoperative AF (AF within 30 days after surgery among patients without prior AF) and long-term AF-related health utilization (event rates of outpatient visits and hospitalizations).

RESULTS: Among 75 782 patients who underwent cardiac surgery (mean age, 66.0 [SD, 11.2] years; 2 2091 [29.2%] women, 25 721 [33.9%] with preexisting AF), 4374 (5.8%) underwent concurrent LAAO, and mean follow-up was 2.1 (SD, 1.9) years. In the 8590 propensity score-matched patients, LAAO was associated with a reduced risk of stroke (1.14 vs 1.59 events per 100 person-years; hazard ratio [HR], 0.73 [95% CI, 0.56-0.96]; P = .03) and mortality (3.01 vs 4.30 events per 100 person-years; HR, 0.71 [95% CI, 0.60-0.84]; P < .001). LAAO was associated with higher rates of AF-related outpatient visits (11.96 vs 10.26 events per person-year; absolute difference, 1.70 [95% CI, 1.60-1.80] events per person-year; rate ratio, 1.17 [95% CI, 1.10-1.24]; P < .001) and hospitalizations (0.36 vs 0.32 event per person-year; absolute difference, 0.04 [95% CI, 0.02-0.06] event per person-year; rate ratio, 1.13 [95% CI, 1.05-1.21]; P = .002). In patients with prior AF (6438/8590 [74.9%]) with vs without LAAO, risk of stroke was 1.11 vs 1.71 events per 100 person-years (HR, 0.68 [95% CI, 0.50-0.92]; P = .01) and risk of mortality was 3.22 vs 4.93 events per 100 person-years (HR, 0.67 [95% CI, 0.56-0.80]; P < .001), respectively. In patients without prior AF (2152/8590 [25.1%]) with vs without LAAO, risk of stroke was 1.23 vs 1.26 events per 100 person-years (HR, 0.95 [95% CI, 0.54-1.68]), risk of mortality was 2.30 vs 2.49 events per 100 person-years (HR, 0.92 [95% CI, 0.61-1.37]), and risk of postoperative AF was 27.7% vs 20.2% events per 100 person-years (HR, 1.46 [95% CI, 1.22-1.73]; P < .001). The interaction term between prior AF and LAAO was not significant (P = .29 for stroke and P = .16 for mortality).

CONCLUSIONS AND RELEVANCE: Among patients undergoing cardiac surgery, concurrent surgical LAAO, compared with no surgical LAAO, was associated with reduced risk of subsequent stroke and all-cause mortality. Further research, including from randomized clinical trials, is needed to more definitively determine the role of surgical LAAO.

来源:JAMA,查看原文。版权归原作者所有。

参考来源

  1. Yao X, Gersh BJ, Holmes DR, et al. Association of Surgical Left Atrial Appendage Occlusion With Subsequent Stroke and Mortality Among Patients Undergoing Cardiac Surgery. JAMA. 2018. PMID: 29800182. doi:10.1001/jama.2018.6024

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。